Celldex Therapeutics | CLDX - Ricavi Di Vendita

Prezzo Delle Azioni
32.03
Cambio Giornaliero
-1.20 -3.61%
Mensile
8.65%
Annuale
53.77%
Q2 Previsione
32.58




I Saldi Cambiamento Data
AbbVie USD 15B 1.62B 2026-03
Agenus USD 34.2M 3.97M 2025-12
Amgen USD 9.9B 340M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Celldex Therapeutics USD 121K 769K 2025-12
Glaxosmithkline GBP 10.09B 1.37B 2026-03
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Northwest Biotherapeutics USD 200K 245K 2025-09
Pfizer USD 17.58B 880M 2025-12
Rigel Pharmaceuticals USD 55.31M 18.47M 2024-09
Roche Holding CHF 15.65B 274.5M 2025-12